# Once-a-day Tacrolimus Conversion Study: The OneTAC Trial

> **NCT02545972** · PHASE4 · UNKNOWN · sponsor: **Newark Beth Israel Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** tacrolimus extended release

## Key facts

- **NCT ID:** NCT02545972
- **Lead sponsor:** Newark Beth Israel Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-02
- **Primary completion:** 2018-11
- **Final completion:** 2019-02
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2016-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02545972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02545972, "Once-a-day Tacrolimus Conversion Study: The OneTAC Trial". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02545972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*